Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo

NCT07253675 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Monkeypox (Mpox)

Interventions

BIOLOGICAL: MVA-SIBP low dose
BIOLOGICAL: MVA-SIBP high dose
BIOLOGICAL: MVA-BN

Sponsor

Shanghai Institute Of Biological Products